Latest Search
Quote
| Back Zoom + Zoom - | ||||
|
JD HEALTH Reaches Strategic Cooperation with Eli Lilly China
Recommend 7 Positive 13 Negative 1 |
||||
|
||||
|
JD HEALTH (06618.HK) officially entered into a strategic cooperation agreement with Eli Lilly China on 29 August, as announced by JD HEALTH. Both parties will fully leverage their complementary advantages in ways like brand, product, channel, technology and services to jointly build an integrated management model of 'drug accessibility + health popular science + digital services' focusing on chronic diseases such as overweight, obesity, diabetes and alopecia areata, aiming to create an innovative one-stop chronic disease management solution, so as to continuously improve patients' treatment accessibility and health management levels. AASTOCKS Financial News Website: www.aastocks.com |
||||
Copied to Clipboard
 |
||||
